CKPT
|
Checkpoint Therapeutics, Inc.
|
US
|
NASDAQ
|
CMMB
|
ChemomAb Therapeutics Ltd.
|
US
|
NASDAQ
|
CMPX
|
Compass Therapeutics, Inc.
|
US
|
NASDAQ
|
CTKB
|
Cytek Biosciences, Inc.
|
US
|
NASDAQ
|
DYAI
|
Dyadic International, Inc.
|
US
|
NASDAQ
|
ENZ
|
Enzo Biochem, Inc.
|
US
|
NYSE
|
FDMT
|
4D Molecular Therapeutics, Inc.
|
US
|
NASDAQ
|
FSTX
|
F-star Therapeutics, Inc.
|
US
|
NASDAQ
|
FUSN
|
Fusion Pharmaceuticals Inc.
|
US
|
NASDAQ
|
GMAB
|
Genmab A/S
|
US
|
NASDAQ
|
HALO
|
Halozyme Therapeutics, Inc.
|
US
|
NASDAQ
|
IFRX
|
InflaRx N.V.
|
US
|
NASDAQ
|
IGMS
|
IGM Biosciences, Inc.
|
US
|
NASDAQ
|
IMNM
|
Immunome, Inc.
|
US
|
NASDAQ
|
IMVT
|
Immunovant, Inc.
|
US
|
NASDAQ
|
IPA
|
ImmunoPrecise Antibodies Ltd.
|
US
|
NASDAQ
|
IPHA
|
Innate Pharma S.A.
|
US
|
NASDAQ
|
IVVD
|
Invivyd, Inc.
|
US
|
NASDAQ
|
MACK
|
Merrimack Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
MGNX
|
MacroGenics, Inc.
|
US
|
NASDAQ
|